iGMDRD28
Canonical SMILES: C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
InChI: InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H
InChI Key: HPJKCIUCZWXJDR-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameLetrozole CHEMBLCHEMBL1444 Pubchem CID3902 KEGG Drug IDD00964 DRUGBANK IDDB01006 Drug StatusAlone Drug targets (TTD)DAP000626 Drug TypeSmall Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAromatase InhibitorsAzolesCytochrome P-450 CYP2A6 InhibitorsCytochrome P-450 CYP2A6 Inhibitors (strong)Cytochrome P-450 Enzyme InhibitorsEndocrine TherapyEnzyme InhibitorsEstrogen AntagonistsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHormone AntagonistsHormone Antagonists and Related AgentsHormones, Hormone Substitutes, and Hormone AntagonistsSteroid Synthesis InhibitorsDrug Targets:
CYP19A1 (P11511)Drug Pathways:
Steroid hormone biosynthesisDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Letrozole
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |